title: Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms.
authors: Jan van Breemen Institute, Amsterdam, The Netherlands.
authors: G M
authors: GM
authors: Bartelds
authors: C A
authors: CA
authors: Wijbrandts
authors: M T
authors: MT
authors: Nurmohamed
authors: G J
authors: GJ
authors: Wolbink
authors: N
authors: N
authors: de Vries
authors: P P
authors: PP
authors: Tak
authors: B A C
authors: BA
authors: Dijkmans
authors: J B A
authors: JB
authors: Crusius
authors: I E
authors: IE
authors: van der Horst-Bruinsma
mesh_terms: D000068879:Adalimumab; D000906:Antibodies / Q000097:blood; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology*; D018501:Antirheumatic Agents / Q000276:immunology* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D004359:Drug Therapy, Combination; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D016753:Interleukin-10 / Q000235:genetics*; D008727:Methotrexate / Q000276:immunology / Q000627:therapeutic use; D020641:Polymorphism, Single Nucleotide; D011446:Prospective Studies
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C508609:IL10 protein, human; D016753:Interleukin-10; D000068879:Adalimumab; D008727:Methotrexate